Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPS
2023-510309-16-00Phase 3Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sternocostoclavicular hyperostosis (SCCH) and Chronic nonbacterial osteomyelitis (CRMO) comparing Pamidronate with Placebo (2 arms). Planned start Aug 2024; status: authorised.
02
Drugs
pamidronate
03
Conditions
sternocostoclavicular hyperostosis (SCCH)Chronic nonbacterial osteomyelitis (CRMO)
Beyond the preview
Go deeper on 2023-510309-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510309-16-00.